BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim JH, Won HJ, Shin YM, Kim PN, Lee SG, Hwang S. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection. Eur J Radiol. 2011;80:e221-e225. [PMID: 20950977 DOI: 10.1016/j.ejrad.2010.09.019] [Cited by in Crossref: 57] [Cited by in F6Publishing: 66] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Bitzer M, Voesch S, Albert J, Bartenstein P, Bechstein W, Blödt S, Brunner T, Dombrowski F, Evert M, Follmann M, La Fougère C, Freudenberger P, Geier A, Gkika E, Götz M, Hammes E, Helmberger T, Hoffmann RT, Hofmann WP, Huppert P, Kautz A, Knötgen G, Körber J, Krug D, Lammert F, Lang H, Langer T, Lenz P, Mahnken A, Meining A, Micke O, Nadalin S, Nguyen HP, Ockenga J, Oldhafer K, Paprottka P, Paradies K, Pereira P, Persigehl T, Plauth M, Plentz R, Pohl J, Riemer J, Reimer P, Ringwald J, Ritterbusch U, Roeb E, Schellhaas B, Schirmacher P, Schmid I, Schuler A, von Schweinitz D, Seehofer D, Sinn M, Stein A, Stengel A, Steubesand N, Stoll C, Tannapfel A, Taubert A, Trojan J, van Thiel I, Tholen R, Vogel A, Vogl T, Vorwerk H, Wacker F, Waidmann O, Wedemeyer H, Wege H, Wildner D, Wittekind C, Wörns MA, Galle P, Malek N. S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome. Z Gastroenterol 2022;60:e186-227. [PMID: 35148560 DOI: 10.1055/a-1589-7854] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Aquina CT, Eskander MF, Pawlik TM. Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature. Front Oncol 2022;12:832405. [DOI: 10.3389/fonc.2022.832405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Fabritius MP, Ben Khaled N, Kunz WG, Ricke J, Seidensticker M. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. J Clin Med 2021;10:5574. [PMID: 34884275 DOI: 10.3390/jcm10235574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bekki Y, Von Ahrens D, Takahashi H, Schwartz M, Gunasekaran G. Recurrent Intrahepatic Cholangiocarcinoma - Review. Front Oncol 2021;11:776863. [PMID: 34746017 DOI: 10.3389/fonc.2021.776863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zori AG, Yang D, Draganov PV, Cabrera R. Advances in the management of cholangiocarcinoma. World J Hepatol 2021; 13(9): 1003-1018 [PMID: 34630871 DOI: 10.4254/wjh.v13.i9.1003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Chu HH, Kim JH, Shin YM, Won HJ, Kim PN. Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes. AJR Am J Roentgenol 2021;217:426-32. [PMID: 34076458 DOI: 10.2214/AJR.20.23461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
7 Shen F, Wang K, Zou Q, Zeng N, Li X, Fang C. Digital Diagnosis and Management of Cholangiocarcinoma. Biliary Tract Surgery 2021. [DOI: 10.1007/978-981-33-6769-2_16] [Reference Citation Analysis]
8 Beal EW, Cloyd JM, Pawlik TM. Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles. J Clin Med 2020;10:E104. [PMID: 33396821 DOI: 10.3390/jcm10010104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
9 Entezari P, Riaz A. Intrahepatic Cholangiocarcinoma.Semin Intervent Radiol. 2020;37:475-483. [PMID: 33328703 DOI: 10.1055/s-0040-1719188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lee SM, Ko HK, Shin JH, Kim JH, Chu HH. Combination of intraoperative radiofrequency ablation and surgical resection for treatment of cholangiocarcinoma: feasibility and long-term survival. Diagn Interv Radiol 2020;26:45-52. [PMID: 31904570 DOI: 10.5152/dir.2019.18552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Saleh M, Virarkar M, Bura V, Valenzuela R, Javadi S, Szklaruk J, Bhosale P. Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings. Abdom Radiol (NY) 2020;45:3662-80. [PMID: 32417933 DOI: 10.1007/s00261-020-02559-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Xiang X, Hu D, Jin Z, Liu P, Lin H. Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma. Front Oncol 2020;10:540662. [PMID: 33134161 DOI: 10.3389/fonc.2020.540662] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Gurmikov BN, Zhavoronkova OI, Stepanova YA, Vishnevsky VA, Chzhao AV. Radiofrequency ablation of intrahepatic cholangiocarcinoma (clinical observation). Ann hir gepatol 2020;25:142-148. [DOI: 10.16931/1995-5464.20203142-148] [Reference Citation Analysis]
14 Cholangiocarcinoma Working Group. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment. Dig Liver Dis 2020;52:1430-42. [PMID: 32952071 DOI: 10.1016/j.dld.2020.08.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
15 Song H, Ding H, Zhu C. CT-Guided Percutaneous Microwave Ablation of Sclerosing Hepatic Carcinoma. Can J Gastroenterol Hepatol 2020;2020:8881978. [PMID: 32733821 DOI: 10.1155/2020/8881978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Brandi G, Rizzo A, Dall’olio FG, Felicani C, Ercolani G, Cescon M, Frega G, Tavolari S, Palloni A, De Lorenzo S, Abbati F, Mollica V, Ricci AD, Serra C. Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience. International Journal of Hyperthermia 2020;37:479-85. [DOI: 10.1080/02656736.2020.1763484] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 17.0] [Reference Citation Analysis]
17 White SB, Maddirela D. Intrahepatic Cholangiocarcinoma. Image-Guided Interventions in Oncology 2020. [DOI: 10.1007/978-3-030-48767-6_8] [Reference Citation Analysis]
18 Díaz-González Á, Vilana R, Bianchi L, García-Criado Á, Rimola J, Rodríguez de Lope C, Ferrer J, Ayuso C, Da Fonseca LG, Reig M, Forner A. Thermal Ablation for Intrahepatic Cholangiocarcinoma in Cirrhosis: Safety and Efficacy in Non-Surgical Patients. J Vasc Interv Radiol 2020;31:710-9. [PMID: 31685360 DOI: 10.1016/j.jvir.2019.06.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
19 Sweeney J, Parikh N, El-Haddad G, Kis B. Ablation of Intrahepatic Cholangiocarcinoma.Semin Intervent Radiol. 2019;36:298-302. [PMID: 31680720 DOI: 10.1055/s-0039-1696649] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
20 Wu L, Tsilimigras DI, Farooq A, Hyer JM, Merath K, Paredes AZ, Mehta R, Sahara K, Shen F, Pawlik TM. Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population‐based analysis. J Surg Oncol 2019;120:1358-64. [DOI: 10.1002/jso.25736] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
21 Yousaf A, Kim JU, Eliahoo J, Taylor-Robinson SD, Khan SA. Ablative Therapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.J Clin Exp Hepatol. 2019;9:740-748. [PMID: 31889756 DOI: 10.1016/j.jceh.2019.08.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
22 Yan X, Wang P, Zhu Z, Ning Z, Xu L, Zhuang L, Sheng J, Meng Z. Site-specific metastases of intrahepatic cholangiocarcinoma and its impact on survival: a population-based study. Future Oncol. 2019;15:2125-2137. [PMID: 31161810 DOI: 10.2217/fon-2018-0846] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
23 Adeva J, Sangro B, Salati M, Edeline J, La Casta A, Bittoni A, Berardi R, Bruix J, Valle JW. Medical treatment for cholangiocarcinoma. Liver Int 2019;39:123-42. [DOI: 10.1111/liv.14100] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 17.3] [Reference Citation Analysis]
24 Qian G, Zhang J, Shen F. Percutaneous Ablation. Intrahepatic Cholangiocarcinoma 2019. [DOI: 10.1007/978-3-030-22258-1_9] [Reference Citation Analysis]
25 Mizrahi JD, Abdel-wahab R, Javle M. Clinical Trials and Novel/Emerging Treatment. Intrahepatic Cholangiocarcinoma 2019. [DOI: 10.1007/978-3-030-22258-1_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Takahashi EA, Kinsman KA, Schmit GD, Atwell TD, Schmitz JJ, Welch BT, Callstrom MR, Geske JR, Kurup AN. Thermal ablation of intrahepatic cholangiocarcinoma: Safety, efficacy, and factors affecting local tumor progression. Abdom Radiol (NY) 2018;43:3487-92. [PMID: 29869103 DOI: 10.1007/s00261-018-1656-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
27 Melekhina OV, Kulezneva YV, Efanov MG, Musatov AB. Combined minimally invasive treatment of liver and bile ducts malignancies. Ann hir gepatol 2018;23:26-36. [DOI: 10.16931/1995-5464.2018226-36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Kis B, El-Haddad G, Sheth RA, Parikh NS, Ganguli S, Shyn PB, Choi J, Brown KT. Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control 2017;24:1073274817729244. [PMID: 28975829 DOI: 10.1177/1073274817729244] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
29 Kang S, Hwang S, Lee Y, Kim K, Ahn C, Moon D, Ha T, Song G, Jung D, Lee S. Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2018;25:240-8. [DOI: 10.1002/jhbp.543] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
30 Tang R, Latchana N, Rahnemai-azar AA, Pawlik TM. Guidelines for Resection of Intrahepatic Cholangiocarcinoma. Primary and Metastatic Liver Tumors 2018. [DOI: 10.1007/978-3-319-91977-5_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Murali N, Savic LJ, Nezami N, Chapiro J, Geschwind J. Regional Liver-Directed Therapies for Intrahepatic Cholangiocarcinoma. Primary and Metastatic Liver Tumors 2018. [DOI: 10.1007/978-3-319-91977-5_9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Mosconi C, Cappelli A, Ascanio S, Pettinari I, Modestino F, Renzulli M, Galaverni MC, Cucchetti A, Gramenzi A, Pettinato C, Golfieri R. Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma. Future Oncology 2017;13:1301-10. [DOI: 10.2217/fon-2017-0022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
33 Wang K, Zhang H, Xia Y, Liu J, Shen F. Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6:79-90. [PMID: 28503555 DOI: 10.21037/hbsn.2017.01.06] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
34 Koay EJ, Odisio BC, Javle M, Vauthey JN, Crane CH. Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments? Hepatobiliary Surg Nutr 2017;6:105-16. [PMID: 28503558 DOI: 10.21037/hbsn.2017.01.16] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
35 Shindoh J. Ablative therapies for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr 2017;6:2-6. [PMID: 28261590 DOI: 10.21037/hbsn.2016.09.07] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
36 Rahnemai-Azar AA, Pandey P, Kamel I, Pawlik TM. Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection. Hepat Oncol 2016;3:223-39. [PMID: 30191045 DOI: 10.2217/hep-2016-0009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
37 Lindsey Davis S. Intrahepatic and Hilar Cholangiocarcinomas: Epidemiology, Basic Principles of Treatment, and Clinical Data. Radiation Therapy for Liver Tumors 2017. [DOI: 10.1007/978-3-319-54531-8_15] [Reference Citation Analysis]
38 Flaherty DC, Bilchik AJ. Radiofrequency ablation of liver tumors. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-34062-5.00126-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
39 Sommer CM, Kauczor HU, Pereira PL. Locoregional Therapies of Cholangiocarcinoma. Visc Med 2016;32:414-20. [PMID: 28229076 DOI: 10.1159/000453010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
40 Soulen MC, Rilling WS. Image-guided therapy of intrahepatic cholangiocarcinoma. Interventional Oncology 2016. [DOI: 10.1017/cbo9781107338555.015] [Reference Citation Analysis]
41 Mosconi C, Gramenzi A, Ascanio S, Cappelli A, Renzulli M, Pettinato C, Brandi G, Monari F, Cucchetti A, Trevisani F, Golfieri R. Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study. Br J Cancer 2016;115:297-302. [PMID: 27336601 DOI: 10.1038/bjc.2016.191] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 6.2] [Reference Citation Analysis]
42 Su XF, Li N, Chen XF, Zhang L, Yan M. Incidence and Risk Factors for Liver Abscess After Thermal Ablation of Liver Neoplasm. Hepat Mon 2016;16:e34588. [PMID: 27642345 DOI: 10.5812/hepatmon.34588] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
43 Uppal DS, Wang AY. Cholangiocarcinoma: Endoscopic therapies. Techniques in Gastrointestinal Endoscopy 2016;18:83-90. [DOI: 10.1016/j.tgie.2016.07.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
44 Pinter M, Trauner M, Peck-Radosavljevic M, Sieghart W. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open. 2016;1:e000042. [PMID: 27843598 DOI: 10.1136/esmoopen-2016-000042] [Cited by in Crossref: 137] [Cited by in F6Publishing: 143] [Article Influence: 22.8] [Reference Citation Analysis]
45 Simo KA, Halpin LE, Mcbrier NM, Hessey JA, Baker E, Ross S, Swan RZ, Iannitti DA, Martinie JB. Multimodality treatment of intrahepatic cholangiocarcinoma: A review: Multimodality Therapy of iCCA. J Surg Oncol 2016;113:62-83. [DOI: 10.1002/jso.24093] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
46 Padia SA. Intrahepatic Cholangiocarcinoma. Tech Vasc Interv Radiol 2015;18:227-35. [PMID: 26615163 DOI: 10.1053/j.tvir.2015.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
47 Han K, Ko HK, Kim KW, Won HJ, Shin YM, Kim PN. Radiofrequency Ablation in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-Analysis. Journal of Vascular and Interventional Radiology 2015;26:943-8. [DOI: 10.1016/j.jvir.2015.02.024] [Cited by in Crossref: 72] [Cited by in F6Publishing: 129] [Article Influence: 10.3] [Reference Citation Analysis]
48 Uppal DS, Wang AY. Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma. World J Gastrointest Endosc 2015; 7(7): 675-687 [PMID: 26140095 DOI: 10.4253/wjge.v7.i7.675] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 69] [Article Influence: 2.6] [Reference Citation Analysis]
49 Lafaro KJ, Cosgrove D, Geschwind JF, Kamel I, Herman JM, Pawlik TM. Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management. Gastroenterol Res Pract 2015;2015:860861. [PMID: 26089873 DOI: 10.1155/2015/860861] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
50 Hwang S, Lee Y, Song G, Park K, Kim K, Ahn C, Moon D, Lee S. Prognostic Impact of Tumor Growth Type on 7th AJCC Staging System for Intrahepatic Cholangiocarcinoma: a Single-Center Experience of 659 Cases. J Gastrointest Surg 2015;19:1291-304. [DOI: 10.1007/s11605-015-2803-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
51 Tabrizian P, Jibara G, Hechtman JF, Franssen B, Labow DM, Schwartz ME, Thung SN, Sarpel U. Outcomes following resection of intrahepatic cholangiocarcinoma. HPB (Oxford) 2015;17:344-51. [PMID: 25395176 DOI: 10.1111/hpb.12359] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
52 Schneider T, Piefel K, Glessmer-junike S, Brunner TB. Körperstereotaxie bei Lebertumoren. Im Focus Onkologie 2014;17:56-63. [DOI: 10.1007/s15015-014-0008-6] [Reference Citation Analysis]
53 Zechlinski JJ, Rilling WS. Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma. Semin Intervent Radiol 2013;30:21-7. [PMID: 24436514 DOI: 10.1055/s-0033-1333650] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
54 Muallem N, Solomon SB. Advances in Interventional Oncology: Percutaneous Therapies. Curr Radiol Rep 2014;2:52. [DOI: 10.1007/s40134-014-0052-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268-1289. [PMID: 24681130 DOI: 10.1016/j.jhep.2014.01.021] [Cited by in Crossref: 795] [Cited by in F6Publishing: 920] [Article Influence: 99.4] [Reference Citation Analysis]
56 Amini N, Ejaz A, Spolverato G, Kim Y, Herman JM, Pawlik TM. Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: a population-based analysis. J Surg Oncol 2014;110:163-70. [PMID: 24676600 DOI: 10.1002/jso.23605] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
57 Butros SR, Shenoy-Bhangle A, Mueller PR, Arellano RS. Radiofrequency ablation of intrahepatic cholangiocarcinoma: feasability, local tumor control, and long-term outcome. Clin Imaging. 2014;38:490-494. [PMID: 24637151 DOI: 10.1016/j.clinimag.2014.01.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
58 Hickey R, Vouche M, Sze DY, Hohlastos E, Collins J, Schirmang T, Memon K, Ryu RK, Sato K, Chen R, Gupta R, Resnick S, Carr J, Chrisman HB, Nemcek AA Jr, Vogelzang RL, Lewandowski RJ, Salem R. Cancer concepts and principles: primer for the interventional oncologist-part II. J Vasc Interv Radiol 2013;24:1167-88. [PMID: 23810312 DOI: 10.1016/j.jvir.2013.04.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
59 Zhang SJ, Hu P, Wang N, Shen Q, Sun AX, Kuang M, Qian GJ. Thermal ablation versus repeated hepatic resection for recurrent intrahepatic cholangiocarcinoma. Ann Surg Oncol 2013;20:3596-602. [PMID: 23715967 DOI: 10.1245/s10434-013-3035-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
60 Fu Y, Yang W, Wu W, Yan K, Xing BC, Chen MH. Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinoma. Chin J Cancer Res. 2011;23:295-300. [PMID: 23359754 DOI: 10.1007/s11670-011-0295-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
61 Junhua A, Yun J, Zhenzhou W, Ling Y, Ding L. Treatment of malignant liver tumors by radiofrequency ablation combined with low-frequency ultrasound radiation with microbubbles. PLoS One 2013;8:e53351. [PMID: 23326418 DOI: 10.1371/journal.pone.0053351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
62 Kamphues C, Seehofer D, Collettini F, Bahra M, Neuhaus P, Wust P, Denecke T, Gebauer B, Schnapauff D. Preliminary experience with CT-guided high-dose rate brachytherapy as an alternative treatment for hepatic recurrence of cholangiocarcinoma. HPB (Oxford) 2012;14:791-7. [PMID: 23134179 DOI: 10.1111/j.1477-2574.2012.00537.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
63 Fu Y, Yang W, Wu W, Yan K, Xing BC, Chen MH. Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma. J Vasc Interv Radiol 2012;23:642-9. [PMID: 22525022 DOI: 10.1016/j.jvir.2012.01.081] [Cited by in Crossref: 55] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
64 Xu HX, Wang Y, Lu MD, Liu LN. Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. Br J Radiol. 2012;85:1078-1084. [PMID: 22374282 DOI: 10.1259/bjr/24563774] [Cited by in Crossref: 46] [Cited by in F6Publishing: 55] [Article Influence: 4.6] [Reference Citation Analysis]
65 Yun BL, Lee JM, Baek JH, Kim SH, Lee JY, Han JK, Choi BI. Radiofrequency ablation for treating liver metastases from a non-colorectal origin. Korean J Radiol 2011;12:579-87. [PMID: 21927559 DOI: 10.3348/kjr.2011.12.5.579] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
66 Patel T. Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol. 2011;8:189-200. [PMID: 21460876 DOI: 10.1038/nrgastro.2011.20] [Cited by in Crossref: 223] [Cited by in F6Publishing: 298] [Article Influence: 20.3] [Reference Citation Analysis]